These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 15126146)
1. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Lai TY; Chan WM; Lam DS Am J Ophthalmol; 2004 May; 137(5):826-33. PubMed ID: 15126146 [TBL] [Abstract][Full Text] [Related]
2. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy. Imai H; Honda S; Nakanishi Y; Yamamoto H; Tsukahara Y; Negi A Br J Ophthalmol; 2006 Dec; 90(12):1524-30. PubMed ID: 16825279 [TBL] [Abstract][Full Text] [Related]
3. Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial. Wu ZH; Lai RY; Yip YW; Chan WM; Lam DS; Lai TY Retina; 2011; 31(7):1378-86. PubMed ID: 21836413 [TBL] [Abstract][Full Text] [Related]
4. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666 [TBL] [Abstract][Full Text] [Related]
6. Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy. Mackay AM; Brown MC; Hagan RP; Fisher AC; Grierson I; Harding SP Doc Ophthalmol; 2007 Sep; 115(2):69-76. PubMed ID: 17671804 [TBL] [Abstract][Full Text] [Related]
7. Multifocal electroretinograms in age-related macular degeneration before and after photodynamic therapy. Kojima M; Yukawa E; Shimoyama K; Nochioka K; Tsujinaka H; Matsuura T Eur J Ophthalmol; 2012; 22(3):412-6. PubMed ID: 21928263 [TBL] [Abstract][Full Text] [Related]
8. Monitoring retinal function in neovascular maculopathy using multifocal electroretinography - early and long-term correlation with clinical findings. Jurklies B; Weismann M; Hüsing J; Sutter EE; Bornfeld N Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):244-64. PubMed ID: 11981638 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration. Tsuchihashi T; Mori K; Peyman G; Shimada Y; Yoneya S Retina; 2009; 29(10):1450-6. PubMed ID: 19816240 [TBL] [Abstract][Full Text] [Related]
10. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration. Lazic R; Gabric N Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776 [TBL] [Abstract][Full Text] [Related]
11. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation. Varano M; Parisi V; Tedeschi M; Sciamanna M; Gallinaro G; Capaldo N; Catalano S; Pascarella A Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1453-62. PubMed ID: 15790915 [TBL] [Abstract][Full Text] [Related]
12. The changes of pattern electroretinography at the early stage of photodynamic therapy. Oner A; Karakucuk S; Mirza E; Erkilic K Doc Ophthalmol; 2005 Sep; 111(2):107-12. PubMed ID: 16514492 [TBL] [Abstract][Full Text] [Related]
13. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization. Isola V; Pece A; Parodi MB Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867 [TBL] [Abstract][Full Text] [Related]
14. [Testing central retinal function with multifocal electroretinography before and after photodynamic therapy]. Rüther K; Breidenbach K; Schwartz R; Hassenstein A; Richard G Ophthalmologe; 2003 Jun; 100(6):459-64. PubMed ID: 12820013 [TBL] [Abstract][Full Text] [Related]
15. A preliminary assessment of macular function by MF-ERG in myopic eyes with CNV with complete response to photodynamic therapy. Moschos MN; Panayotidis D; Moschos MM; Bouros C; Theodossiadis PG; Theodossiadis GP Eur J Ophthalmol; 2003 Jun; 13(5):461-7. PubMed ID: 12841569 [TBL] [Abstract][Full Text] [Related]
16. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. Chaudhary V; Mao A; Hooper PL; Sheidow TG Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration. Pece A; Isola V; Vadalà M; Calori G Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590 [TBL] [Abstract][Full Text] [Related]
20. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration. Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]